Signal active
Investment Firm
Overview
Farallon Capital Management, L.L.C. is an American capital management firm that manages funds on behalf of institutions and individuals with significant capital. Based in San Francisco, the firm was founded by Thomas F. Steyer in March of 1986. As of September 2008, it has around 150 employees.
While it invests across the capital structure and in all asset classes, a large amount of its investments are in risk arbitrage, restructuring and recapitalization. Investments include public and private debt and equity securities, direct investments in private companies, and real estate. Farallon's real estate investments span the United States, Europe, Latin America and India.
Highlights
1986
Financial Services
251-500
87
21
45
Late Stage Venture, Early Stage Venture, Private Equity
Private Equity Firm, Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
Farallon Capital Management, established in 1986 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture, Private Equity investments across Photography, Video, Broadcasting, Media and Entertainment, Financial Services, Venture Capital, Finance, Business Development, Angel Investment, Biotechnology. The organization boasts a portfolio of 86 investments, with an average round size of $196.9M and 45 successful exits. Their recent investments include Youku, Sutter Hill Ventures, Brookside Capital, Chengwei Capital, Maverick Ventures. The highest investment round they participated in was $1668.6B. Among their most notable exits are Youku and Sutter Hill Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
Investment portfolio
87
17
21
45
Investments
87
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Jun 20, 2024 | Tectonic Therapeutic | Biotechnology | 130.7M |
Jun 28, 2024 | Savara Pharmaceuticals | Biotechnology | 100.0M |
Jul 16, 2024 | Cardurion Pharmaceuticals | Biotechnology | 260.0M |
Jul 16, 2024 | ATLAS CAPITAL GROUP | Property Management | 985.0M |
Exits
45
Funding Timeline
87
0
4
Funding Rounds
87
Farallon Capital Management has raised 87 rounds. Their latest funding was raised on Jul 16, 2024 from a Debt Financing - ATLAS CAPITAL GROUP round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Jun 20, 2024 | Post-IPO Equity - Tectonic Therapeutic | - | 130.7M | - |
Jun 28, 2024 | Post-IPO Equity - Savara Pharmaceuticals | - | 100.0M | - |
Jul 16, 2024 | Series B - Cardurion Pharmaceuticals | - | 260.0M | - |
Jul 16, 2024 | Debt Financing - ATLAS CAPITAL GROUP | - | 985.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.